17.93 USD
-0.68
3.65%
At close May 14, 4:00 PM EDT
After hours
17.93
+0.00
0.00%
1 day
-3.65%
5 days
4.85%
1 month
14.79%
3 months
-17.07%
6 months
-10.71%
Year to date
-6.17%
1 year
-6.47%
5 years
12.63%
10 years
-35.85%
 

About: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Employees: 12,300

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

809% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $1.75M

67% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 5 (+2) [Q4]

2.28% more ownership

Funds ownership: 110.96% [Q3] → 113.24% (+2.28%) [Q4]

0% less capital invested

Capital invested by funds: $3.76B [Q3] → $3.76B (-$3.01M) [Q4]

7% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 41

2% less funds holding

Funds holding: 292 [Q3] → 285 (-7) [Q4]

26% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 119

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$17
5%
downside
Avg. target
$19.20
7%
upside
High target
$23
28%
upside

5 analyst ratings

positive
20%
neutral
80%
negative
0%
UBS
Kevin Caliendo
53% 1-year accuracy
10 / 19 met price target
0%upside
$18
Neutral
Maintained
5 May 2025
Piper Sandler
Jason Bednar
40% 1-year accuracy
16 / 40 met price target
5%downside
$17
Neutral
Maintained
30 Apr 2025
B of A Securities
Michael Cherny
64% 1-year accuracy
18 / 28 met price target
28%upside
$23
Buy
Maintained
29 Apr 2025
JP Morgan
Rachel Vatnsdal
50% 1-year accuracy
7 / 14 met price target
6%upside
$19
Neutral
Maintained
6 Mar 2025
Morgan Stanley
Erin Wright
56% 1-year accuracy
15 / 27 met price target
6%upside
$19
Equal-Weight
Maintained
6 Mar 2025

Financial journalist opinion

Based on 8 articles about NVST published over the past 30 days

Neutral
Zacks Investment Research
1 day ago
Understanding Envista (NVST) Reliance on International Revenue
Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Understanding Envista (NVST) Reliance on International Revenue
Neutral
Zacks Investment Research
1 week ago
NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash
Envista delivers better-than-expected top and bottom-line results for the first quarter of 2025.
NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash
Neutral
Seeking Alpha
1 week ago
Envista Holdings Corporation (NVST) Q1 2025 Earnings Conference Call Transcript
Envista Holdings Corporation (NYSE:NVST ) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ET Company Participants Jim Gustafson - VP, IR Paul Keel - President and CEO Eric Hammes - CFO Conference Call Participants Jon Block - Stifel Jason Bednar - Piper Sandler Elizabeth Anderson - Evercore ISI Jeff Johnson - Baird Allen Lutz - Bank of America Steven Valiquette - Mizuho Securities Brandon Vazquez - William Blair Erin Wright - Morgan Stanley Michael Cherny - Leerink Partners Operator Hello, my name is Madison and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Envista Holdings Corporation's First Quarter 2025 Earnings Results Conference Call.
Envista Holdings Corporation (NVST) Q1 2025 Earnings Conference Call Transcript
Positive
Zacks Investment Research
1 week ago
Compared to Estimates, Envista (NVST) Q1 Earnings: A Look at Key Metrics
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Envista (NVST) Q1 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
1 week ago
Envista (NVST) Beats Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.26 per share a year ago.
Envista (NVST) Beats Q1 Earnings and Revenue Estimates
Neutral
PRNewsWire
1 week ago
Envista Reports First Quarter 2025 Results
BREA, Calif. , May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended March 28, 2025.
Envista Reports First Quarter 2025 Results
Negative
Seeking Alpha
2 weeks ago
Envista Holdings: A Mixed Picture
Today, we take a deeper look at Envista Holdings Corporation, a dental supply and equipment company. The stock appears to be trying to bottom after a recent decline and despite negative analyst firm opinion on the shares. The company has recently instituted a significant stock buyback program and from a historical perspective, the shares are cheap on a price to sales ratio basis.
Envista Holdings: A Mixed Picture
Negative
Zacks Investment Research
2 weeks ago
Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline
Positive
Zacks Investment Research
1 month ago
Should You Continue to Hold NVST Stock in Your Portfolio?
Investors are optimistic about Envista, thanks to its strong momentum in the Specialty Products and Technologies segment.
Should You Continue to Hold NVST Stock in Your Portfolio?
Neutral
PRNewsWire
1 month ago
Envista Schedules First Quarter 2025 Earnings Call
BREA, Calif. , April 8, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2025 on Thursday, May 1, 2025.
Envista Schedules First Quarter 2025 Earnings Call
Charts implemented using Lightweight Charts™